title: [Neurological phenocopying].
abstract: OBJECTIVE
  To expand the -supposedly- narrow relationships that exist between genes and clinical syndromes by reflecting on several illustrative examples that disturb current simplistic genotype: phenotype correlations, and to explore a variety of biological mechanisms that account for this emerging phenomenon.
  
  
  METHODS
  Because it is well known that mutations in a single gene can give rise to numerous phenotypes, it would appear, at least intuitively, that the converse relationship might also hold true: that different genotypes may converge on just one single phenotype. Several examples taken from the study of selected neurological diseases illustrate that the latter principle indeed occurs in nature because disparate human genetic anomalies manifest similarly by exhibiting only a relatively limited phenotypic repertoire. This interesting biological phenomenon and vexing clinical problem is best described as phenocopying. Conditions such as spinal muscular atrophy, congenital glycosylation disorders, and mitochondrial diseases are but a few notorious examples of phenocopying.
  
  
  CONCLUSIONS
  The nervous system is endowed with a limited number of genes and of types of molecules and, especially during development, its functional repertoire, at least from an observable point of view, is also limited. Therefore, ample genotyping capabilities are necessary to avoid erring in the process of diagnostic attribution because of phenocopying.
authors.affiliation: Departamentos de Neurología, Fisiología y Pediatría, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8813, USA. dr.juan.pascual@gmail.com
authors.forename: J M
authors.initials: JM
authors.lastname: Pascual
mesh_terms: D015220:Calcium Channels / Q000235:genetics; D017362:Cyclic AMP Response Element-Binding Protein / Q000235:genetics; D004272:DNA, Mitochondrial / Q000235:genetics; D016189:Dystrophin / Q000172:deficiency / Q000235:genetics; D047108:Embryonic Development; D018740:Genetic Heterogeneity; D005838:Genotype; D006801:Humans; D008305:Malignant Hyperthermia / Q000235:genetics; D009134:Muscular Atrophy, Spinal / Q000235:genetics; D009136:Muscular Dystrophies / Q000235:genetics; D020388:Muscular Dystrophy, Duchenne / Q000235:genetics; D009154:Mutation; D020294:Myasthenic Syndromes, Congenital / Q000235:genetics; D062553:NAV1.4 Voltage-Gated Sodium Channel; D009419:Nerve Tissue Proteins / Q000235:genetics; D009422:Nervous System Diseases / Q000196:embryology / Q000235:genetics / Q000473:pathology*; D010641:Phenotype; D016601:RNA-Binding Proteins / Q000235:genetics; D055532:SMN Complex Proteins; D015222:Sodium Channels / Q000235:genetics; D014897:Spinal Muscular Atrophies of Childhood / Q000235:genetics; D020864:Calcium Channels, N-Type
chemical_list: D015220:Calcium Channels; D017362:Cyclic AMP Response Element-Binding Protein; D004272:DNA, Mitochondrial; D016189:Dystrophin; D062553:NAV1.4 Voltage-Gated Sodium Channel; D009419:Nerve Tissue Proteins; D016601:RNA-Binding Proteins; D055532:SMN Complex Proteins; D015222:Sodium Channels; C105656:CACNA1A protein, human; D020864:Calcium Channels, N-Type; C106251:SCN4A protein, human